Apheresis Collection & Vein-to-Vein Logistics
End-to-end logistics solutions for cell and gene therapy workflows — from leukapheresis collection to final drug product delivery. We manage the transport of blood-derived materials and finished products under controlled conditions, ensuring full traceability and compliance. Our network across Europe and the U.S. enables seamless, time-sensitive, cross-border apheresis collection, storage, and distribution — ensuring materials arrive safely, on time, and in optimal condition.
Apheresis
Collection Services
Autologous and allogeneic cell collection services through our legacy network of apheresis sites across Europe and the U.S.
Expertise in harvesting peripheral blood mononuclear cells (PBMCs), including T cells, monocytes, and other target populations
Nearly 3,000 successful collections performed across multiple indications, geographies, and technologies
Benefit:
Reliable, high-quality starting material from trusted partners — with full traceability, Chain of Identity (COI), and regulatory compliance.
End-to-End Apheresis Site Management
Identification, qualification, and contracting of apheresis sites
Auditing, monitoring, and training of site personnel for specific protocols and procedures
Optimization of collection parameters and technical settings
Benefit:
You gain a fully managed, compliant collection network without the operational burden.
Integrated Logistics & Transport
Full logistics support including shipping studies, transport validation, and real-time tracking
Transport of apheresis materials between manufacturing and clinic, with optimized transatlantic workflows to shorten vein‑to‑vein time
Managed via our CONNECT™ software platform for cloud-based manufacturing orchestration and full visibility
Benefit:
Global cold‑chain integrity with full Chain of Custody (COC) and oversight from pickup to delivery — reducing risks, operational complexity, and timelines.
Storage, Packaging & Distribution
GxP-compliant storage for finished goods across all temperature ranges: LN₂, -80 °C, -20 °C, +2 to +8 °C, and +15 to +25 °C
Secondary labeling and distribution services for investigational medicinal products (IMPs)
Wide range of validated packaging solutions (e.g., dry shippers, dry ice, ambient)
Global distribution capabilities across the EU, UK, China and U.S.
Benefit:
Your products are stored and shipped under optimal conditions — ready for use when and where you need them.
More Ways We Help
cGMP Manufacturing and Quality Control
Cell therapy and viral vector
expertise with robust in-house QC capabilities
Lentiviral & Gammaretroviral Vector Production & Testing
Viral vectors development and manufacturing - scalable RUO & GMP grades
Analytical
Development
Analytical development include
method development,
optimization, and validation
Process Development & Tech Transfer
Scalable, optimized processes
with successful transfer from lab to GMP
Apheresis Collection
& Logistics
Seamless needle‑to‑needle coordination across 150+ EU/US legacy apheresis sites — from apheresis to patient delivery
Storage
& Distribution
Proprietary global GxP logistics, controlled storage, and cold chain management
Quality & Regulatory Support & Qualified Person Services
QP batch release under EU GMP and global compliance support
Extensive Global Heritage in Apheresis Management
SCTbio draws on a long-standing legacy of working with more than 150 qualified and trained cell-collection sites across Europe and the USA. We provide dedicated apheresis support, with rapid reactivation and site‑specific procedure alignment to secure high‑quality clinical starting material.
